Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 30 citing van Bommel: Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. (0.08 sec) 

Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients


S Akram, DS Pardi, JA Schaffner, TC Smyrk - Clinical Gastroenterology and Hepatology, 2007 - Elsevier
Sclerosing mesenteritis (SM) is a rare fibroinflammatory disorder of unknown
etiology that primarily affects the small bowel mesentery. 1 The first known
series, comprising 34 cases of “retractile mesenteritis and mesenteric ...
Cited by 19 - Related articles - All 22 versions

Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis


PJ Scheel, J Piccini, MH Rahman, L Lawler, T … - The Journal of Urology, 2007 - Elsevier
Seven patients were treated with mycophenolate mofetil and prednisone. Five of
the 7 patients had bilateral ureteral obstruction and 1 had unilateral
obstruction requiring ureteral stents. Baseline and followup laboratory ...
Cited by 16 - Related articles - All 14 versions

Autoimmune aspects of chronic periaortitis


A Vaglio, P Greco, D Corradi, A Palmisano, D … - Autoimmunity Reviews, 2006 - Elsevier
Chronic periaortitis (CP) includes idiopathic retroperitoneal fibrosis,
inflammatory abdominal aortic aneurysms and perianeurysmal retroperitoneal
fibrosis. These entities are characterised by a fibro-inflammatory tissue ...
Cited by 15 - Related articles - All 2 versions

Retroperitoneal fibrosis: evolving concepts


A Vaglio, A Palmisano, D Corradi, C Salvarani … - Rheumatic Disease Clinics of NOrth America, 2007 - Elsevier
Retroperitoneal fibrosis (RPF) is a rare fibro-inflammatory condition that is
idiopathic in most cases, but may be secondary to various causes. Although the
cause and pathogenesis of the idiopathic form are unknown, immunogenetic ...
Cited by 8 - Related articles - All 22 versions

Clinical value of gallium-67 SPECT scintigraphy in the diagnostic and therapeutic evaluation …


EFH Van Bommel, C Siemes, SJ van der Veer, … - Journal of internal medicine, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 4 - Related articles - BL Direct - All 3 versions

Atypical Ormond's disease associated with bile duct stricture mimicking cholangiocarcinoma


M Quante, B Appenrodt, S Randerath, M Wolff … - Scandinavian Journal of Gastroenterology, 2009 - informahealthcare.com
A 55-year-old woman with suspected hilar cholangiocarcinoma presented with
jaundice and dilated intrahepatic bile ducts owing to high-grade hepatic duct
confluence stenosis. The suspected tumour and the entire extrahepatic bile ...
Cited by 4 - Related articles - All 5 versions

Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal …


NC Pract - Nephron Clin Pract, 2008 - content.karger.com
Background/Aims: Retroperitoneal fibrosis (RPF) is a chronic inflammatory
disorder causing obstructive nephropathy and renal failure. We reviewed our
management of this condition. Method: All patients with RPF treated at a ...
Cited by 3 - Related articles - BL Direct - All 4 versions

Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update …


S Guest - Peritoneal Dialysis International, 2009 - pdiconnect.com
Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal
dialysis (PD) and is characterized by symptoms mimicking an intermittent small
bowel ileus such as nausea, vomiting, and intestinal obstruction (1). ...
Cited by 2 - Related articles - All 3 versions

A worrying thought--could there be a connection between encapsulating peritoneal sclerosis …

- oxfordjournals.org
A Korzets, Y Ori, D Zevin, A Chagnac, M … - Nephrology Dialysis Transplantation, 2006 - ERA-EDTA
Pharmacological therapeutic choices are based on anecdotal evidence alone, but a
combination of prednisone and tamoxifen has been used in an attempt to reduce
both the inflammatory and fibrotic changes associated with this disease ...
Cited by 2 - Related articles - BL Direct - All 6 versions

Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation


PJ Scheel Jr, N Feeley - Medicine, 2009 - journals.lww.com
Abstract: Retroperitoneal fibrosis (RPF) is an inflammatory disorder that
affects the infrarenal great vessels and surrounding structures. Although first
described in 1948 by Ormond, much of the information currently available on ...
Cited by 2 - Related articles - All 3 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google